We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$1.8B
AUM Growth
-$71.6M
Cap. Flow
-$42M
Cap. Flow %
-2.34%
Top 10 Hldgs %
31.1%
Holding
353
New
47
Increased
41
Reduced
115
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 22.18%
2 Healthcare 16.19%
3 Financials 14.04%
4 Consumer Discretionary 13.86%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MANH icon
101
Manhattan Associates
MANH
$12.4B
$4.51M 0.25%
+33,900
New +$4.59M
MPLX icon
102
MPLX
MPLX
$59.8B
$4.48M 0.25%
149,332
-37,330
-20% -$1.17M
LNG icon
103
Cheniere Energy
LNG
$54B
$4.44M 0.25%
26,776
-4,920
-16% -$746K
STKL
104
DELISTED
SunOpta
STKL
$4.35M 0.24%
+477,640
New +$4.53M
LTHM
105
DELISTED
Livent Corporation
LTHM
$4.34M 0.24%
141,770
-3,350
-2% -$93.9K
FLYW icon
106
Flywire
FLYW
$2.06B
$4.34M 0.24%
+189,100
New +$4.51M
LITE icon
107
Lumentum
LITE
$47B
$4.31M 0.24%
62,900
-1,400
-2% -$116K
HURN icon
108
Huron Consulting
HURN
$2.67B
$4.3M 0.24%
64,920
-1,310
-2% -$86.9K
B
109
Barrick Mining
B
$60.1B
$4.28M 0.24%
276,340
EVH icon
110
Evolent Health
EVH
$385M
$4.26M 0.24%
+118,570
New +$4.18M
CELH icon
111
Celsius Holdings
CELH
$7.47B
$4.23M 0.24%
+139,920
New +$4.38M
GPRE icon
112
Green Plains
GPRE
$1.15B
$4.2M 0.23%
144,368
+62,960
+77% +$2.13M
CZR icon
113
Caesars Entertainment
CZR
$6.06B
$4.13M 0.23%
127,860
-2,090
-2% -$90.9K
ITCI
114
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.1M 0.23%
88,180
-2,000
-2% -$104K
APLS
115
DELISTED
Apellis Pharmaceuticals
APLS
$3.95M 0.22%
+57,890
New +$3.43M
MODN
116
DELISTED
MODEL N, INC.
MODN
$3.95M 0.22%
115,483
+89,834
+350% +$2.6M
HLIT icon
117
Harmonic Inc
HLIT
$1.14B
$3.92M 0.22%
299,578
+116,810
+64% +$1.26M
MAT icon
118
Mattel
MAT
$4.47B
$3.91M 0.22%
206,630
-51,320
-20% -$1.15M
DNLI icon
119
Denali Therapeutics
DNLI
$3.78B
$3.91M 0.22%
+127,460
New +$4.14M
SUM
120
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$3.88M 0.22%
164,647
+33,134
+25% +$889K
CCSI icon
121
Consensus Cloud Solutions
CCSI
$681M
$3.75M 0.21%
79,357
-1,660
-2% -$85.4K
RVNC
122
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.73M 0.21%
138,347
+9,034
+7% +$183K
SPT icon
123
Sprout Social
SPT
$534M
$3.36M 0.19%
55,364
-29,790
-35% -$1.79M
MAS icon
124
Masco
MAS
$14.8B
$3.35M 0.19%
71,800
TMCI icon
125
Treace Medical Concepts
TMCI
$258M
$3.33M 0.19%
+150,670
New +$2.91M

Similar funds

Castleark Management's Q3 2022 Portfolio in Review

As of Q3 2022, Castleark Management held 353 positions worth $1.8B, down 3.8% from $1.87B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Castleark Management's Q3 2022 filing shows 47 new, 41 increased, 115 reduced and 69 closed positions. Its largest new stake was ServiceNow: 372,050 shares worth $28.1M. The largest sale was NVIDIA, an estimated $22.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Castleark Management's largest Q3 2022 buy was ServiceNow: 372,050 shares worth $28.1M.
  • Castleark Management added most to State Street Financial Select Sector SPDR ETF in Q3 2022, an estimated $19.8M increase.
  • Castleark Management's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $22.9M.
  • Castleark Management fully exited Invesco QQQ Trust in Q3 2022, selling an estimated $17.3M.
  • Castleark Management's ten largest holdings make up 31% of its $1.8B portfolio in Q3 2022.
  • Castleark Management opened 47 new positions and closed 69 in Q3 2022.
  • Castleark Management's portfolio value fell 3.8% quarter-over-quarter to $1.8B.

Based on Castleark Management's 13F filing for Q3 2022, filed 15 Nov 2022.